Maternal RSV Task Force Emphasizes the Immediate Opportunity to Protect All Infants in Canada from RSV Disease [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
OTTAWA, ON July 2, 2024 /CNW/ - Today, the Federation of Medical Women of Canada (FMWC) released a white paper on behalf of the recently convened Maternal RSV Task Force. The task force was brought together by the FMWC to address the urgent need for Respiratory Syncytial Virus (RSV) prevention in infants for the upcoming 2024 - 2025 RSV season. Chief among the recommendations in the resulting white paper was a call to offer RSV protection to all infants now. While provincial governments evaluate, create and implement possible universal programs, the Maternal RSV Task Force calls for urgent education, communication and awareness to seize this unprecedented opportunity to protect more infants from RSV disease this RSV season The Time is Now Health Canada recently approved two new products offering protection against RSV in infants in the critical early months of life. These include Nirsevimab (Beyfortus TM , Sanofi), a monoclonal antibody which can be given to newborns and infants
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit [BNN Bloomberg (Canada)]BNN Bloomberg
- Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD [Yahoo! Finance]Yahoo! Finance
- GSK to Buy CureVac's Covid-19, Flu Vaccine Rights for Up to $1.56 Billion [Yahoo! Finance]Yahoo! Finance
- Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data [Yahoo! Finance]Yahoo! Finance
- Liposomal Doxorubicin Market is Expected to Reach US$ 2,367.5 Million by 2034, Rising at a 6.3% CAGR | Future Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 7/2/24 - Form 6-K
- 6/28/24 - Form 11-K
- 6/28/24 - Form 11-K
- SNY's page on the SEC website